Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293776327> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4293776327 endingPage "226" @default.
- W4293776327 startingPage "226" @default.
- W4293776327 abstract "Background and Aims: Atrial fibrillation (AF) is the frequent arrhythmia found in clinical practice and. s associated with atrial structural changes that may have an inflammatory basis. Whereas the pleiotropic effect of statines, we aimed to assess the influence of high intensity statins on recurrence AF after successful cardioversion.Methods: 126 patients with non-valvular persistent AF (mean age 64.6 ± 9.7) where enrolled in this study and followed up during 24 weeks. .The echocardiography examination and 24-hour ambulatory Holter monitoring ECG were registered in each patient. Blood samples were tested on the serum levels of hs-CRP and IL-6. All patients were divided in to two groups. The first group was treated by Atorvastatin 40mg or Rosuvastatine 10mg; the second group has administrated placebo (P). Prophylactic drug therapy with Amiodarone (200-300 mg daily) was administered to all patients.Results: The obtained results have shown that the basis data of hs-CRP and of IL-6 levels in patients with persistent AF were increased (0.82±0.32 mg/dL and 22±11 pg/ml accordingly). After 24 weeks treatment in first group these indices were significantly reduced (0.48±0.11 mg/dL, p < 0.001 and 12.1±4.9 pg/ml, p<0.001 accordingly vs. second group with P; 0.76± 0.32 mg/dL, 18.1± 3.9 pg/ml,). The follow-up during 24 weeks has shown that primary end-point in first group reduces AF recurrence to 4.6% compared 19% in the placebo group.Conclusions: High intensity statins have been effective in the prevention of AF recurrence after successful cardioversion. Background and Aims: Atrial fibrillation (AF) is the frequent arrhythmia found in clinical practice and. s associated with atrial structural changes that may have an inflammatory basis. Whereas the pleiotropic effect of statines, we aimed to assess the influence of high intensity statins on recurrence AF after successful cardioversion. Methods: 126 patients with non-valvular persistent AF (mean age 64.6 ± 9.7) where enrolled in this study and followed up during 24 weeks. .The echocardiography examination and 24-hour ambulatory Holter monitoring ECG were registered in each patient. Blood samples were tested on the serum levels of hs-CRP and IL-6. All patients were divided in to two groups. The first group was treated by Atorvastatin 40mg or Rosuvastatine 10mg; the second group has administrated placebo (P). Prophylactic drug therapy with Amiodarone (200-300 mg daily) was administered to all patients. Results: The obtained results have shown that the basis data of hs-CRP and of IL-6 levels in patients with persistent AF were increased (0.82±0.32 mg/dL and 22±11 pg/ml accordingly). After 24 weeks treatment in first group these indices were significantly reduced (0.48±0.11 mg/dL, p < 0.001 and 12.1±4.9 pg/ml, p<0.001 accordingly vs. second group with P; 0.76± 0.32 mg/dL, 18.1± 3.9 pg/ml,). The follow-up during 24 weeks has shown that primary end-point in first group reduces AF recurrence to 4.6% compared 19% in the placebo group. Conclusions: High intensity statins have been effective in the prevention of AF recurrence after successful cardioversion." @default.
- W4293776327 created "2022-08-31" @default.
- W4293776327 creator A5026119208 @default.
- W4293776327 creator A5062896355 @default.
- W4293776327 creator A5080379869 @default.
- W4293776327 date "2022-08-01" @default.
- W4293776327 modified "2023-09-25" @default.
- W4293776327 title "The impact of high intensity statins long treatment for recurrence of atrial fibrillation after successful cardioversion" @default.
- W4293776327 doi "https://doi.org/10.1016/j.atherosclerosis.2022.06.883" @default.
- W4293776327 hasPublicationYear "2022" @default.
- W4293776327 type Work @default.
- W4293776327 citedByCount "0" @default.
- W4293776327 crossrefType "journal-article" @default.
- W4293776327 hasAuthorship W4293776327A5026119208 @default.
- W4293776327 hasAuthorship W4293776327A5062896355 @default.
- W4293776327 hasAuthorship W4293776327A5080379869 @default.
- W4293776327 hasBestOaLocation W42937763271 @default.
- W4293776327 hasConcept C126322002 @default.
- W4293776327 hasConcept C142724271 @default.
- W4293776327 hasConcept C164705383 @default.
- W4293776327 hasConcept C204787440 @default.
- W4293776327 hasConcept C27081682 @default.
- W4293776327 hasConcept C2777289489 @default.
- W4293776327 hasConcept C2777482532 @default.
- W4293776327 hasConcept C2778094803 @default.
- W4293776327 hasConcept C2779161974 @default.
- W4293776327 hasConcept C2780499067 @default.
- W4293776327 hasConcept C2909021529 @default.
- W4293776327 hasConcept C35785553 @default.
- W4293776327 hasConcept C42219234 @default.
- W4293776327 hasConcept C71924100 @default.
- W4293776327 hasConceptScore W4293776327C126322002 @default.
- W4293776327 hasConceptScore W4293776327C142724271 @default.
- W4293776327 hasConceptScore W4293776327C164705383 @default.
- W4293776327 hasConceptScore W4293776327C204787440 @default.
- W4293776327 hasConceptScore W4293776327C27081682 @default.
- W4293776327 hasConceptScore W4293776327C2777289489 @default.
- W4293776327 hasConceptScore W4293776327C2777482532 @default.
- W4293776327 hasConceptScore W4293776327C2778094803 @default.
- W4293776327 hasConceptScore W4293776327C2779161974 @default.
- W4293776327 hasConceptScore W4293776327C2780499067 @default.
- W4293776327 hasConceptScore W4293776327C2909021529 @default.
- W4293776327 hasConceptScore W4293776327C35785553 @default.
- W4293776327 hasConceptScore W4293776327C42219234 @default.
- W4293776327 hasConceptScore W4293776327C71924100 @default.
- W4293776327 hasLocation W42937763271 @default.
- W4293776327 hasOpenAccess W4293776327 @default.
- W4293776327 hasPrimaryLocation W42937763271 @default.
- W4293776327 hasRelatedWork W1990523300 @default.
- W4293776327 hasRelatedWork W2014195660 @default.
- W4293776327 hasRelatedWork W2074022304 @default.
- W4293776327 hasRelatedWork W2355016336 @default.
- W4293776327 hasRelatedWork W2380493707 @default.
- W4293776327 hasRelatedWork W2386917658 @default.
- W4293776327 hasRelatedWork W2588211330 @default.
- W4293776327 hasRelatedWork W2890796321 @default.
- W4293776327 hasRelatedWork W3012508844 @default.
- W4293776327 hasRelatedWork W4205726400 @default.
- W4293776327 hasVolume "355" @default.
- W4293776327 isParatext "false" @default.
- W4293776327 isRetracted "false" @default.
- W4293776327 workType "article" @default.